oped countries, there are wide gaps in the understanding of its cause. Extensive epidemiologic studies have revealed the importance of diabetes, hyperlipidemia, hypertension, and cigarette smoking in the atherosclerotic process and provide clinically important variables through which this disease process can potentially be favorably modified.' Also, effective medical therapies as well as improved mechanical techniques such as angioplasty and bypass surgery have improved our ability to control the clinical manifestations ofvascular disease. Despite these advances, the primary inciting events in the atherosclerotic process remain poorly defined.
The response to injury hypothesis, as has been recently reviewed by Ross,2 has gained widespread acceptance as a conceptual framework for understanding the pathogenesis of atherosclerosis. A notable shortcoming of this hypothesis is that the clinically important "injurious" agents that may be responsible for initiating atherosclerosis remain elusive. We will address experimental and clinical work that strongly supports an important role for viruses in this disease process.
A brief review of the pathology of atherosclerosis is essential in understanding how viruses may be involved in the atherosclerotic process. The microscopic appearance of atherosclerotic plaques can be viewed as a heterogeneous spectrum. At one end is a lesion characterized by intimal smooth muscle cell proliferation, believed to represent the earliest stage in this disease process.3 Benditt and Benditt4 have studied atherosclerotic plaques from the aorta and iliac arteries of female patients who were heterozygous for the glucose 6-phosphate dehydrogenase isoenzyme and found that plaques contained predominantly one isoenzyme form 
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as compared with normal arteries, which contained a mixture of the isoenzymes. These findings, although controversial, suggest that the intimal proliferation of atherosclerosis may represent a monoclonal proliferative process. These authors speculated that chemical or infectious mutagenic agents were more likely to be responsible for initiating atherosclerosis than nonspecific physical injury, which would be expected to cause a nonspecific polyclonal growth response. According to this theory, fatty-proliferative and amorphous fatty lesions represent evolutionary stages in the disease process as smooth muscle cells mature, accumulate lipid, and eventually become senescent.
Attempting to study the possible influence of viruses in atherosclerosis is a difficult task in humans. Fortunately, a fascinating and underutilized animal preparation exists that has provided insight into this area.
In the late 1940s, work by Paterson and Cottral5 revealed a strong association between coronary atherosclerosis and lymphomatosis known as Marek's disease in chickens. The exact significance of this association was not appreciated until decades later when the causal agent of this lymphomatosis was identified as a herpes-type DNA virus, subsequently called Marek's disease virus (MDV).6 This virus produces a T cell lymphoma that carries a high mortality rate. Fortunately, a closely related virus, herpes virus of turkeys (HVT) was isolated and serves as a very effective vaccine.7 In 1978, Fabricant et al.8 reported that infecting pathogen-free chickens with MDV not only resulted in lymphomatous disease but also produced the vascular lesions that closely resembled human atherosclerosis. Subsequent work by Minick et al.9 expanded upon this work. They reported a 14% prevalence of grossly visible atherosclerosis in MDV-infected chickens compared with 0% in the uninfected control group. Microscopic evidence of atherosclerosis was seen in 65% of infected animals but in none of the control animals. Cholesterol feeding increased the prevalence of grossly visible and microscopic disease and changed the character of the lesions from more purely proliferative lesions to fatty-proliferative and fatty lesions, CIRCULATION consistent with the hypothesis that once a lesion is initiated by a viral stimulus, conventional risk factors may be capable of accelerating the disease process. Also in this study, vascular smooth muscle cells were found by immunofluorescence techniques to contain MDV, despite the absence of endothelial cell damage. 9 These data suggest that viral transformation ofvascular smooth muscle cells might be of critical etiologic significance in atherosclerosis, and that concomitant endothelial damage may not be required for initiation of the disease process.
The cellular mechanism responsible for these vascular changes induced by viral infection has been examined. Work by Fabricant et al.'0 demonstrated that a feline herpes virus could produce intracellular and extracellular cholesterol crystals when used to infect cultured feline renal cells, suggesting that alterations in lipid metabolism may occur with viral infection.
Later work by Fabricant et al.11 in the early 1980s studied the effect of MDV on cultured chicken aortic smooth muscle cell lipid metabolism. Infected cells contained a significantly higher content of cholesterol, cholesterol esters, fatty acids, triglycerides, and total lipids compared with uninfected cells. Also, this virus resulted in an increase in the cholesterol esters containing saturated fatty acids compared with those containing unsaturated fatty acids. Of interest was that HVT, the vaccine virus for Marek's disease, did not produce these alterations in smooth muscle cell lipid composition, suggesting that these alterations in lipid metabolism were due specifically to MDV infection and not a nonspecific response to viral injury.
These observations were extended to a preparation in vivo.12 Aortic lipid content was analyzed in postmortem specimens from a group of MDV-infected chickens and from an uninfected control group. Tissue from the infected group had a significantly higher content of cholesterol, cholesterol esters, triglycerides, phospholipids, and total lipids. It was also found that administration of HVT vaccine before MDV challenge largely prevented the aortic lipid alterations produced by MDV infection. Also Burch et al.13 speculated in 1971 that "viral lesions are suggested as an initiating factor in the production ofvascular diseases in man, possibly including atherosclerosis." Burch encountered a young patient a few years later who died of fulminant coxsackie myocarditis. At postmortem, there was atherosclerosis in the ascending aorta out of proportion to his age and definable risk factors. The presence of accelerated atherosclerosis was ascribed to his viral infection and Burch felt this was evidence in support of his 1971 hypothesis.14 Despite this hypothesis, the role of viruses in human atherosclerosis received little attention until recently.
Work by Melnick et al. 15 using electron microscopic and immunofluorescence techniques revealed evidence of cytomegalovirus antigens in arterial smooth muscle cells from a small but significant number of patients undergoing coronary artery bypass graft surgery and carotid endarterectomy. Work by Benditt et al.,16 who were also looking for evidence of herpes virus in human vascular tissue, was carried out using DNA hybridization techniques. They were unable to find evidence for cytomegalovirus infection in smooth muscle cells, but did find evidence of smooth muscle cell infection with the closely related herpes simplex virus. Although both groups found evidence of viruses in arterial smooth muscle cells, the explanation for their differing results remains unknown. More recent work has shown that herpes virus can alter cellular lipid metabolism and lipid composition and content in human arterial smooth muscle cells, inducing changes similar to those produced by the MDV in chickens.17
In summary, experimental work strongly supports a role for viral infection in experimental atherosclerosis, and it is plausible that infection may initiate atherosclerosis by transforming arterial smooth muscle cells and fundamentally altering cellular lipid metabolism." Preliminary work by Melnick and Benditt and their colleagues15' 16 in humans is suggestive, although less compelling, than the experimental observations in animals that herpes-type DNA viruses may have a role in the pathogenesis of human atherosclerosis. It is therefore possible that ubiquitous viruses may prove to be one of the most clinically important "injurious" agents responsible for inciting atherosclerosis. Varying exposure to these viral agents, as well as intrinsic differences in the immune responses to these viral illnesses, may account for some of the marked variability in the degree of atherosclerotic vascular disease seen in patients with seemingly equal risk profiles. Likewise, it is interesting to speculate whether viral infection may have a role in the clinical problems of restenosis after angioplasty and the accelerated atherosclerosis seen in patients on immunosuppressive doses of corticosteroids, both of which remain essentially unexplained.
Clearly, future investigation is needed to define what role if any viral infection has in the pathogenesis of human atherosclerosis. The viral cause hypothesis is compatible with the response to injury hypothesis, and may simply represent one potential means of arterial injury. Furthermore, a viral cause would not negate the importance of the well-defined risk factors in the atherosclerotic process.
Great progress has been made in treating arterial vascular disease with effective medical therapy and mechanical revascularization techniques. It is conceivable as we focus increasingly on measures aimed toward primary prevention of atherosclerosis that such measures may ultimately include a variety of antiviral strategies, even including the use of vaccination.
